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Background
Wheat gluten proteins are very complex proteins con-
taining hundreds of components present as monomers,
oligomers and polymers that by definition are not solu-
ble in water. To improve utilization, gluten proteins can
be hydrolyzed by enzymes or acid. This increases solubi-
lity and provide proteins with new functional properties.
During the last decade, cases of severe allergic reaction
to hydrolyzed wheat proteins have been reported in sub-
jects tolerant to wheat.
Methods
Brown Norway rats bred and kept on a gluten-free diet
for at least three generations were sensitized either
orally or intraperitoneally (i.p.) with two different com-
mercial gluten products; unmodified (U-gluten) and
enzymatic hydrolyzed gluten (EH-gluten). No adjuvant
was used for sensitization. For oral sensitization rats
were dosed by daily gavage for 35 days with 0.2, 2 or 20
mg of gluten protein suspended in PBS. For i.p. sensiti-
zation rats were immunized three times two weeks apart
with 200 µg of gluten protein in PBS. Sera obtained at
sacrifice were analyzed by ELISA for levels of specific
IgG1 and IgE and for IgG1-binding capacity by inhibi-
tion ELISA. Biological functionality of specific IgE was
examined by rat basophilic leukemia cell (RBL) assay.
Results
Enzymatic hydrolysis significantly increased solubility of
gluten proteins. Regardless of the route of dosing,
U-gluten and EH-gluten were found to have sensitizing
capacity. Sensitization by the i.p. route induced a strong
specific IgG1 and IgE response in all animals. No differ-
ence in levels or functionality of specific IgG1 and IgE
were found between i.p. immunized groups. A clear dose-
response in levels of specific IgG1 and IgE was found for
rats dosed orally with EH-gluten while U-gluten induced
comparable antibody levels and number of responders
irrespective of the dose used for oral sensitization. All
doses of U-gluten gave a higher response than low dose
EH-gluten and a lower response than high dose EH-
gluten. As for the i.p. studies, IgG1-binding was not influ-
enced by the gluten product used for oral sensitization.
Conclusion
Our results indicate that epitopes are not lost and new
epitopes are not formed or disclosed during enzymatic
hydrolysis. While enzymatic hydrolysis does not change
sensitization by the i.p. route, dose-response was clearly
changed when dosed orally. As EH-gluten was a less
potent sensitizer at low dose our results indicate that
enzymatic hydrolysis reduces sensitizing capacity despite
the fact that epitopes seem unharmed.
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